Home > Annual Financials > NATURAL CAPSULES

NATURAL CAPSULES Financial Statement Analysis
[BOM: 524654]

The Revenues of NATURAL CAPSULES have increased by 27.62% YoY .
The Earnings Per Share (EPS) of NATURAL CAPSULES has decreased by -70.09 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

NATURAL CAPSULES Last 5 Annual Financial Results
[BOM: 524654]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹172 Cr₹135 Cr₹80 Cr₹6,155,485 Cr₹60 Cr
Expenses ₹138 Cr₹111 Cr₹68 Cr₹5,610,887 Cr₹55 Cr
Operating Profit (Excl OI) ₹34 Cr₹24 Cr₹11 Cr₹544,598 Cr₹5.05 Cr
Other Income ₹1.62 Cr₹2.22 Cr₹0.73 Cr₹95,310 Cr₹1.14 Cr
Interest ₹3.73 Cr₹2.08 Cr₹0.54 Cr₹90,763 Cr₹0.53 Cr
Depreciation ₹7.21 Cr₹5.04 Cr₹4.31 Cr₹412,072 Cr₹3.20 Cr
Profit Before Tax ₹25 Cr₹19 Cr₹9.16 Cr₹137,072 Cr₹2.07 Cr
Profit After Tax ₹18 Cr₹14 Cr₹6.91 Cr₹85,755 Cr₹1.92 Cr
Consolidated Net Profit ₹18 Cr₹14 Cr₹6.85 Cr₹85,755 Cr₹1.92 Cr
Earnings Per Share (Rs)₹5.95₹19.89₹19.56₹10.99₹1.38
PAT Margin (%)3.5710.7010.308.691.39
ROE(%)3.4017.8919.1811.741.54
ROCE(%)5.0016.1820.7514.523.71
Total Debt/Equity(x)0.530.780.630.160.11

Key Financials

Market Cap : ₹ 278.2 Cr
Revenue (TTM) : ₹ 160.6 Cr
Net Profit(TTM) : ₹ 2.2 Cr
EPS (TTM) : ₹ 2.1
P/E (TTM) : 128.4

Industry Peers & Returns1W1M1Y
NATURAL CAPSULES -1.1% -0.5% -25%
SUN PHARMACEUTICAL INDUSTRIES -5.3% -7.8% 24.1%
CIPLA -1.9% -6.9% 3.6%
DR REDDYS LABORATORIES -8.3% -14.9% 0.8%
ZYDUS LIFESCIENCES -5.7% -4% 23.6%
DIVIS LABORATORIES -3.9% -7.9% 51%
MANKIND PHARMA -5.9% -14% 21%
TORRENT PHARMACEUTICALS 2.9% -0% 34%
LUPIN -3.8% -12.1% 39.2%


NATURAL CAPSULES Revenues
[BOM: 524654]

Y-o-Y

27.62 %

5 Yr CAGR

30.31 %

Years Revenues % Change
Mar2024 ₹172 Cr
27.62
Mar2023 ₹135 Cr
69.86
Mar2022 ₹80 Cr
-100.00
Mar2021 ₹6,155,485 Cr
10,296,796.44
Mar2020 ₹60 Cr -


NATURAL CAPSULES Operating Profit
[BOM: 524654]

Y-o-Y

41.27 %

5 Yr CAGR

61.43 %

Years Operating Profit % Change
Mar2024 ₹34 Cr
41.27
Mar2023 ₹24 Cr
118.83
Mar2022 ₹11 Cr
-100.00
Mar2021 ₹544,598 Cr
10,779,740.86
Mar2020 ₹5.05 Cr -

Operating Margins
Y-o-Y

10.73 %

5 Yr CAGR

23.89 %

Years Operating Margin% % Change
Mar2024 19.91%
10.73
Mar2023 17.98%
28.80
Mar2022 13.96%
57.74
Mar2021 8.85%
4.73
Mar2020 8.45% -

NATURAL CAPSULES Profit After Tax
[BOM: 524654]

Y-o-Y

34.49 %

5 Yr CAGR

76.06 %

Years Profit After Tax % Change
Mar2024 ₹18 Cr
34.49
Mar2023 ₹14 Cr
100.29
Mar2022 ₹6.85 Cr
-99.99
Mar2021 ₹85,755 Cr
4,466,298.44
Mar2020 ₹1.92 Cr -

PAT Margins
Y-o-Y

-66.64 %

5 Yr CAGR

26.59 %

Years PAT Margin(%) % Change
Mar2024 3.57 %
-66.64
Mar2023 10.7 %
3.88
Mar2022 10.3 %
18.53
Mar2021 8.69 %
525.18
Mar2020 1.39 % -

NATURAL CAPSULES Earnings Per Share (EPS)
[BOM: 524654]

Y-o-Y

-70.09 %

5 Yr CAGR

44.10 %

Years EPS % Change
Mar2024 ₹5.95
-70.09
Mar2023 ₹20
1.69
Mar2022 ₹20
77.98
Mar2021 ₹11
696.38
Mar2020 ₹1.38 -

NATURAL CAPSULES Return on Capital Employed (ROCE)
[BOM: 524654]

Y-o-Y

-69.10 %

5 Yr CAGR

7.75 %

Years ROCE % Change
Mar2024 5%
-69.10
Mar2023 16.18%
-22.02
Mar2022 20.75%
42.91
Mar2021 14.52%
291.37
Mar2020 3.71% -

NATURAL CAPSULES Share Price vs Sensex

Current Share Price : ₹270.1
Current MarketCap: ₹ 278.2 Cr
Updated EOD on :Jan 29,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
NATURAL CAPSULES

-1.1%

-0.5%

-25%

SENSEX

0.2%

-2.2%

7.7%

NATURAL CAPSULES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about NATURAL CAPSULES Financials


How the annual revenues of NATURAL CAPSULES have changed ?

The Revenues of NATURAL CAPSULES have increased by 27.62% YoY .

How the Earnings per Share (EPS) of NATURAL CAPSULES have changed?

The Earnings Per Share (EPS) of NATURAL CAPSULES has decreased by -70.09 % YoY .